FIELD: medicine, allergology. SUBSTANCE: either hormonal or immunocorrecting preparations should be lymphotropically introduced due to subcutaneous injection. Injection area is mastoid processes from both sides and area of pretracheal fiber. Single dosage corresponds to 1/3-1/5 against average daily therapeutic dose. Therapy course lasts for 1-5 d. The suggested method enables to create high concentrations of medicinal preparation in pathological focus. EFFECT: higher efficiency of therapy. 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CORRECTION OF IMMUNE INSUFFICIENCY IN PATIENTS WITH PULMONARY TUBERCULOSIS | 2004 |
|
RU2254872C1 |
METHOD OF CHRONIC TONSILLITIS TREATMENT | 2008 |
|
RU2357732C1 |
METHOD FOR TREATING THE CASES OF NONSPECIFIC METROENDOMETRITITIS | 1998 |
|
RU2141266C1 |
METHOD FOR TREATMENT OF PATIENTS WITH ENCYSTED TUBERCULOSIS PLEURITIS | 2003 |
|
RU2239437C1 |
CONSERVATIVE METHOD FOR TREATING URETHRAL STRICTURES | 2000 |
|
RU2194537C2 |
METHOD OF TREATMENT OF PATIENT WITH VIBRATION DISEASE | 1998 |
|
RU2155040C2 |
METHOD FOR DIAGNOSING SEVERE CASES OF BRONCHIAL ASTHMA | 1995 |
|
RU2120635C1 |
METHOD OF TREATING ACUTE INGUINAL LYMPHADENITIS | 1995 |
|
RU2141835C1 |
DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING PULMONARY TUBERCULOSIS | 1998 |
|
RU2143223C1 |
METHOD OF TREATING ALLERGIC RHINITIS IN CHILDREN | 2009 |
|
RU2410134C1 |
Authors
Dates
2003-07-27—Published
2001-10-03—Filed